Creating the Conditions for Manufacturing Success
DTG has launched a new Manufacturing & Supply Chain Transformation service designed to help Pharmaceutical and Biotechnology organisations improve operational performance, strengthen supply chain resilience, and create the foundations for sustainable long-term growth.
The launch comes at a time when Manufacturing Site Leaders, Supply Chain Executives, and Biotech leadership teams are facing unprecedented levels of complexity. Increasingly sophisticated medicines, heightened regulatory scrutiny, expanding manufacturing networks, and growing pressure to improve performance and sustainability are placing significant demands on operations across the industry.
While the need for transformation has never been clearer, the reality for many organisations is that operational challenges continue to consume leadership attention. Site performance issues, supply chain disruptions, financial pressures, and day-to-day operational demands often leave little capacity to implement the changes needed to build a more efficient, resilient, and scalable operating model.
“Across the industry we see how many organisations know exactly what needs to change,” said DTG’s CEO Dave Tudor. “The challenge is creating the space, focus, and capability required to make transformation happen for tomorrow’s growth – while continuing to deliver today’s operational commitments.”
Working in partnership with Manufacturing, Supply Chain and Operational Leaders, DTG’s new Manufacturing & Supply Chain Transformation service extends leadership teams with the people who have the lived transformational experience and performance expertise. Built specifically for regulated manufacturing environments, the service is designed to help organisations identify the root causes limiting performance, improve operational alignment, strengthen supply resilience, and implement sustainable improvements that deliver measurable business outcomes.
DTG works alongside Site Directors seeking to regain control of operational performance, Heads of Supply Chain looking to improve resilience and governance, and high-growth Biotech organisations navigating the transition from development to commercial manufacturing.
A core principle of the service is that transformation should be built with organisations rather than delivered to them. DTG understands that manufacturing transformation is not simply about technology, it’s about creating the conditions for lasting operational success.
By strengthening internal capability, leadership, and ownership, DTG helps ensure that improvements are embedded within the organisation and continue to deliver value long after an engagement has concluded.
The new service complements DTG’s broader expertise in digital manufacturing transformation, data integration, and sustainability. The objective for DTG is to enable leaders to unlock the true value of manufacturing in an increasingly challenging business environment; improve throughput, yield, quality, and capacity utilisation while accelerating technology transfer and reducing compliance risk.
Ultimately, DTG is here to help leaders bring innovative medicines to patients faster.
